PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.
BMJ. 2022 May 4;377:e069116. doi: 10.1136/bmj-2021-069116.
BMJ. 2022.
PMID: 35508321
Free article.